# Evaluation of a Novel Intrasaccular Embolization Device for the Treatment of Intracranial Aneurysms

Study · id `cardio:ct-nct07022249` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07022249](<https://clinicaltrials.gov/study/NCT07022249>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07022249

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT07022249. Allocation not applicable; no masking; primary purpose treatment. Start 2025-06 (anticipated); primary completion 2027-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT07022249, source copy `cardio:ctgov-nct07022249-2025-06-15`, retrieved 2026-11-18)
- Planned start: 2025-06 (anticipated) (ClinicalTrials.gov record NCT07022249, source copy `cardio:ctgov-nct07022249-2025-06-15`, retrieved 2026-11-18)
- Primary completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT07022249, source copy `cardio:ctgov-nct07022249-2025-06-15`, retrieved 2026-11-18)
- Completion: 2027-06 (anticipated) (ClinicalTrials.gov record NCT07022249, source copy `cardio:ctgov-nct07022249-2025-06-15`, retrieved 2026-11-18)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07022249-2025-06-15`, retrieved 2026-11-18)

## The registry's words

- Brief title: Evaluation of a Novel Intrasaccular Embolization Device for the Treatment of Intracranial Aneurysms
- Condition: Intracranial Aneurysms
- Intervention (Device): Intrasaccular Embolization Device
- Lead sponsor: Ton-Bridge Medical Tech. Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry lists this organization as the lead sponsor: Ton-Bridge Medical Tech. Co., Ltd (`cardio:org-ton-bridge-medical-tech-co-ltd`)

## Provenance

Content hash: 9fcc4d7b9098bbf9df620457cacfd90892e05b1ed004cf63f8c5f72fa8e8da9a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
